Watson to Match Patients to Clinical Trials

IBM’s cognitive computer will be individualizing trial plans for cancer patients at the Mayo Clinic.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, CLOCKREADYIBM’s Watson is one busy machine. Already deployed to aid researchers and clinicians at several institutions, the “cognitive computer” is now helping oncologists at the Mayo Clinic in Rochester, Minnesota, to sift through reams of patient records and sort individuals afflicted with cancer into appropriate clinical trials. “In an area like cancer, where time is of the essence, the speed and accuracy that Watson offers will allow us to develop an individualized treatment plan more efficiently so we can deliver exactly the care that the patient needs,” Steven Alberts, chair of medical oncology at Mayo Clinic, said in a statement.

Watson could ease the burden on clinical trial coordinators by matching thousands of patients, each with a unique health history and suite of symptoms, with thousands of experimental protocols that are designed to capture specific individuals. This should benefit not only patients, but the scientists who are running trials, said investigators at the Mayo Clinic. “With shorter times from initiation to completion of trials, our research teams will have the capacity for deeper, more complete investigations,” Nicholas LaRusso, a Mayo Clinic gastroenterologist and the project lead for the Mayo-IBM Watson collaboration, said in the statement. “Coupled with increased accuracy, we will be able to develop, refine and improve new and better techniques in medicine at a higher level.”

The computer, which will become more efficient ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
Unraveling Complex Biology with Advanced Multiomics Technology

Unraveling Complex Biology with Five-Dimensional Multiomics

Element Bioscience Logo
Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Resurrecting Plant Defense Mechanisms to Avoid Crop Pathogens

Twist Bio 
The Scientist Placeholder Image

Seeing and Sorting with Confidence

BD
The Scientist Placeholder Image

Streamlining Microbial Quality Control Testing

MicroQuant™ by ATCC logo

Products

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies

waters-logo

How Alderley Analytical are Delivering eXtreme Robustness in Bioanalysis